|
مقاله
|
Abstract
|
|
|
|
Title:
|
The effect of the intavitreal erythropoietin injection to treatment of non arthritic anterior ischemic optic neuropathy during 2015-2016 in Isfahan Feiz Hospital
|
|
Author(s):
|
dehghani AliReza, Ghanbari Heshmatolah, Kamani Mehdi, Akhlaghi MohamadReza.
|
|
Presentation Type:
|
Poster
|
|
Subject:
|
Posterior Segment and Uveitis
|
|
Others:
|
|
|
Presenting Author:
|
|
|
Name:
|
Alireza Dehghani
|
|
Affiliation :(optional)
|
Associate professor of ophthalmology,Isfahan Eye Research Center,Isfahan university of Medical sciences, Isfahan-Iran
|
|
E mail:
|
adehghani45@yahoo.com
|
|
Phone:
|
32363685
|
|
Mobile:
|
09133109705
|
|
|
|
|
Purpose:
|
non arthritic anterior ischemic optic neuropathy(NAION), is a disease with serious complications that already doesn’t have any standard treatment. Some studies and experiences had shown intravitreal erythropoietin injection has a neuroprotective effect. But in was some different and inconsistent results in that studies. So the aim of this study was determining of intavitreal injection of erythropoietin for treatment of the disease.
|
|
Methods:
|
in a clinical trial study 40 eyes (from 38 patients) were selected and randomly divided in two groups . in the first group 2000 IU erythropoietin was injected in vitreus and the second group have not received erythropoietin. visual aquity and visual field was measured In the before and Three months After treatment and compared between the two groups.
|
|
Results:
|
according to the results of the study, mean of visual aquity was improved in the treatment group (P<0.001) but the visual aquity wasn’t different in the control group(P=0.27). Also Pattern stasndard deviation was improved in the treatment group (P=0.047) but not statistically significant in the control group (p=0.13).
|
|
Conclusion:
|
intravitreal erythropoietin injection in patients with non arthritic anterior ischemic optic neuropathy lead to remarkable and significant improvement of visual aquity and field. So this treatment strategy advice in patients that have suitable condition and no have any contraindication by ophtalologists.
|
|
Attachment:
|
|
|
|